1. |
Loring DW, Meador KJ, Lee GP, et al. Wada memory asymmetries predict verbal memory decline after anterior temporal lobectomy. Neurology, 1995, 45(7): 1329-1333.
|
2. |
Loring DW, Murro AM, Meador KJ, et al. Wada memory testing and hippocampal volume measurements in the evaluation for temporal lobectomy. Neurology, 1993, 43(9): 1789-1793.
|
3. |
Wada J. Youthful season revisited. Brain Cogn, 1997, 33(1): 7-10.
|
4. |
Wada J. Clinical experimental observations of carotid artery injections of sodium amytal. Brain Cogn, 1997, 33(1): 11-13.
|
5. |
Wada J. Intracarotid injection of sodium amytal for the lateralization of cerebral speech dominance: experimental and clinical observations.1960. J Neurosurg, 2007, 106(6): 1117-1133.
|
6. |
Penfield W, Milner B. Memory deficit produced by bilateral lesions in the hippocampal zone. AMA Arch Neurol Psychiatry, 1958, 79(5): 475-497.
|
7. |
Branch C, Milner B, Rasmussen T. Intracarotid sodium amytal for the lateralization of cerebral speech dominance: observations in 123 patients. J Neurosurg, 1964, 21: 399-405.
|
8. |
Fedio P, August A, Patronas N, et al. Semantic, phonological, and perceptual changes following left and right intracarotid injection (Wada) with a low amytal dosage. Brain Cogn, 1997, 33(1): 98-117.
|
9. |
Loring DW, Meador KJ, Lee GP, et al. Stimulus timing effects on Wada memory testing. Arch Neurol, 1994, 51(8): 806-810.
|
10. |
Bouwer MS, Jones-Gotman M, Gotman J. Duration of sodium amytal effect: behavioral and EEG measures. Epilepsia, 1993, 34(1): 61-68.
|
11. |
Ravdin LD, Perrine K, Haywood CS, et al. Serial recovery of language during the intracarotid amobarbital procedure. Brain Cogn, 1997, 33(2): 151-160.
|
12. |
Wada J. A new method for determination of the side of cerebral speech dominance: clinico-experimental observations on the intra-carotid injection of sodium amytal phospholipi. Med Biol, 1949, 21: 39-43.
|
13. |
Mariappan R, Manninen P, McAndrews MP, et al. Intracarotid etomidate is a safe alternative to sodium amobarbital for the Wada test. J Neurosurg Anesthesiol, 2013, 25(4): 408-413.
|
14. |
Takayama M, Miyamoto S, Ikeda A, et al. Intracarotid propofol test for speech and memory dominance in man. Neurology, 2004, 63(3): 510-515.
|
15. |
Mirenda J, Broyles G. Propofol as used for sedation in the ICU. Chest, 1995, 108(2): 539-548.
|
16. |
Wolf A, Weir P, Segar P, et al. Impaired fatty acid oxidation in propofol infusion syndrome. Lancet, 2001, 357(9256): 606-607.
|
17. |
Mikuni N, Takayama M, Satow T, et al. Evaluation of adverse effects in intracarotid propofol injection for Wada test. Neurology, 2005, 65(11): 1813-1816.
|
18. |
Jones-Gotman M, Sziklas V, Djordjevic J, et al. Etomidate speech and memory test (eSAM): a new drug and improved intracarotid procedure. Neurology, 2005, 65(11): 1723-1729.
|
19. |
Mazzola L, Mauguière F, Isnard J. Electrical stimulations of the human insula: their contribution to the ictal semiology of insular seizures. J Clin Neurophysiol, 2017, 34(4): 307-314.
|
20. |
Buchtel HA, Passaro EA, Selwa LM, et al. Sodium methohexital (brevital) as an anesthetic in the Wada test. Epilepsia, 2002, 43(9): 1056-1061.
|
21. |
Gaillard WD, Balsamo L, Xu B, et al. fMRI language task panel improves determination of language dominance. Neurology, 2004, 63(8): 1403-1408.
|
22. |
Rothermel LK. Newer pharmacologic agents for procedural sedation of children in the emergency department–etomidate and propofol. Curr Opin Pediatr, 2003, 15(2): 200-203.
|